These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 20842820

  • 1. [Serum C-peptide concentration in overweight and obese women with polycystic ovary syndrome].
    Maciejewska-Jeske M, Szczesna A, Męczekalski B.
    Pol Merkur Lekarski; 2010 Aug; 29(170):93-9. PubMed ID: 20842820
    [Abstract] [Full Text] [Related]

  • 2. Plasma visfatin level in women with polycystic ovary syndrome.
    Dıkmen E, Tarkun I, Cantürk Z, Cetınarslan B.
    Gynecol Endocrinol; 2011 Jul; 27(7):475-9. PubMed ID: 20586547
    [Abstract] [Full Text] [Related]

  • 3. Neuropeptide Y, leptin, galanin and insulin in women with polycystic ovary syndrome.
    Baranowska B, Radzikowska M, Wasilewska-Dziubińska E, Kapliński A, Roguski K, Płonowski A.
    Gynecol Endocrinol; 1999 Oct; 13(5):344-51. PubMed ID: 10599552
    [Abstract] [Full Text] [Related]

  • 4. Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance.
    Tan BK, Heutling D, Chen J, Farhatullah S, Adya R, Keay SD, Kennedy CR, Lehnert H, Randeva HS.
    Diabetes; 2008 Jun; 57(6):1501-7. PubMed ID: 18375437
    [Abstract] [Full Text] [Related]

  • 5. Impact of glycemic variations on the regulation of androgen metabolism in obese women with polycystic ovary syndrome.
    Ludwig AK, Goharian LG, Dietze T, Tauchert S, Rudolf S, Diedrich K, Schweiger U, Oltmanns KM.
    Fertil Steril; 2009 Jul; 92(1):271-6. PubMed ID: 18692843
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study.
    Florakis D, Diamanti-Kandarakis E, Katsikis I, Nassis GP, Karkanaki A, Georgopoulos N, Panidis D.
    Int J Obes (Lond); 2008 Apr; 32(4):692-9. PubMed ID: 18071341
    [Abstract] [Full Text] [Related]

  • 10. Circulating ghrelin levels and the polycystic ovary syndrome: correlation with the clinical, hormonal and metabolic features.
    Daghestani MH, Daghestani MH, El-Mazny A.
    Eur J Obstet Gynecol Reprod Biol; 2011 Mar; 155(1):65-8. PubMed ID: 21216086
    [Abstract] [Full Text] [Related]

  • 11. Abdominal subcutaneous fat gene expression and circulating levels of leptin and adiponectin in polycystic ovary syndrome.
    Lecke SB, Mattei F, Morsch DM, Spritzer PM.
    Fertil Steril; 2011 May; 95(6):2044-9. PubMed ID: 21419406
    [Abstract] [Full Text] [Related]

  • 12. Serum leptin levels correlate with obesity parameters but not with hyperinsulinism in women with polycystic ovary syndrome.
    Erturk E, Kuru N, Savci V, Tuncel E, Ersoy C, Imamoglu S.
    Fertil Steril; 2004 Nov; 82(5):1364-8. PubMed ID: 15533361
    [Abstract] [Full Text] [Related]

  • 13. Relationship of the metabolic syndrome and obesity to polycystic ovary syndrome: a controlled, population-based study.
    Korhonen S, Hippeläinen M, Niskanen L, Vanhala M, Saarikoski S.
    Am J Obstet Gynecol; 2001 Feb; 184(3):289-96. PubMed ID: 11228476
    [Abstract] [Full Text] [Related]

  • 14. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance.
    Sepilian V, Nagamani M.
    J Soc Gynecol Investig; 2005 Feb; 12(2):129-34. PubMed ID: 15695109
    [Abstract] [Full Text] [Related]

  • 15. [Study on the relationship between serum adiponectin and insulin resistance in women with polycystic ovary syndrome].
    Yang XF, Ren FR, Guo SP.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):261-3. PubMed ID: 16759463
    [Abstract] [Full Text] [Related]

  • 16. Comparison of fibrinolytic and metabolic system parameters in obese patients with polycystic ovary syndrome and women with simple obesity.
    Słopień R, Lewandowski K, Kolacz E, Zawilska K, Warenik-Szymankiewicz A.
    Gynecol Endocrinol; 2006 Nov; 22(11):651-4. PubMed ID: 17145652
    [Abstract] [Full Text] [Related]

  • 17. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome.
    Pehlivanov B, Mitkov M.
    Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711
    [Abstract] [Full Text] [Related]

  • 18. Polycystic ovary syndrome: obesity, insulin resistance, hyperandrogenism.
    Lo Dico G, Alongi G, Savatteri L, Rini GB, Mascellino MR, Di Fede G, Rizzo G.
    Acta Eur Fertil; 1989 Apr; 20(5):309-13. PubMed ID: 2700062
    [Abstract] [Full Text] [Related]

  • 19. Increased follistatin levels after oral contraceptive treatment in obese and non-obese women with polycystic ovary syndrome.
    Chen MJ, Yang WS, Chen HF, Kuo JJ, Ho HN, Yang YS, Chen SU.
    Hum Reprod; 2010 Mar; 25(3):779-85. PubMed ID: 20093255
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.